These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 27799305)
1. Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition. Pan XY; Zhao W; Wang CY; Lin J; Zeng XY; Ren RX; Wang K; Xun TR; Shai Y; Liu SW J Biol Chem; 2016 Dec; 291(50):26177-26187. PubMed ID: 27799305 [TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation. Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242 [TBL] [Abstract][Full Text] [Related]
3. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response. Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131 [TBL] [Abstract][Full Text] [Related]
4. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb. Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990 [TBL] [Abstract][Full Text] [Related]
5. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors. Painter MM; Zaikos TD; Collins KL J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396 [TBL] [Abstract][Full Text] [Related]
6. HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo. Timmons A; Fray E; Kumar M; Wu F; Dai W; Bullen CK; Kim P; Hetzel C; Yang C; Beg S; Lai J; Pomerantz JL; Yukl SA; Siliciano JD; Siliciano RF Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15763-15771. PubMed ID: 32571938 [TBL] [Abstract][Full Text] [Related]
7. Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency. Li Z; Wu J; Chavez L; Hoh R; Deeks SG; Pillai SK; Zhou Q PLoS Pathog; 2019 Jan; 15(1):e1007498. PubMed ID: 30645648 [TBL] [Abstract][Full Text] [Related]
8. PR-957, a selective immunoproteasome inhibitor, reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1. Lin J; Zhang X; Lu W; Xu X; Pan X; Liang T; Duan S; Chen Y; Li L; Liu S Biochem Pharmacol; 2018 Oct; 156():511-523. PubMed ID: 30170098 [TBL] [Abstract][Full Text] [Related]
9. Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal. Cisneros WJ; Soliman SHA; Walter M; Simons LM; Cornish D; De Fabritiis S; Halle AW; Kim EY; Wolinsky SM; Lorenzo-Redondo R; Shilatifard A; Hultquist JF PLoS Pathog; 2024 Sep; 20(9):e1012083. PubMed ID: 39259751 [TBL] [Abstract][Full Text] [Related]
10. PARP1 Might Substitute HSF1 to Reactivate Latent HIV-1 by Binding to Heat Shock Element. Xu X; Lin Y; Zeng X; Yang C; Duan S; Ding L; Lu W; Lin J; Pan X; Ma X; Liu S Cells; 2022 Jul; 11(15):. PubMed ID: 35954175 [TBL] [Abstract][Full Text] [Related]
11. A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b. Liang T; Zhang X; Lai F; Lin J; Zhou C; Xu X; Tan X; Liu S; Li L Biochem Pharmacol; 2019 Jun; 164():237-251. PubMed ID: 30991051 [TBL] [Abstract][Full Text] [Related]
12. Heat Shock Factor 1 Mediates Latent HIV Reactivation. Pan XY; Zhao W; Zeng XY; Lin J; Li MM; Shen XT; Liu SW Sci Rep; 2016 May; 6():26294. PubMed ID: 27189267 [TBL] [Abstract][Full Text] [Related]
13. Short communication: SAHA (vorinostat) induces CDK9 Thr-186 (T-loop) phosphorylation in resting CD4+ T cells: implications for reactivation of latent HIV. Ramakrishnan R; Liu H; Rice AP AIDS Res Hum Retroviruses; 2015 Jan; 31(1):137-41. PubMed ID: 24528253 [TBL] [Abstract][Full Text] [Related]
14. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566 [TBL] [Abstract][Full Text] [Related]
15. TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb. Ma X; Yang T; Luo Y; Wu L; Jiang Y; Song Z; Pan T; Liu B; Liu G; Liu J; Yu F; He Z; Zhang W; Yang J; Liang L; Guan Y; Zhang X; Li L; Cai W; Tang X; Gao S; Deng K; Zhang H Elife; 2019 Jan; 8():. PubMed ID: 30652970 [TBL] [Abstract][Full Text] [Related]
16. Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways. Mbonye U; Leskov K; Shukla M; Valadkhan S; Karn J PLoS Pathog; 2021 Sep; 17(9):e1009581. PubMed ID: 34529720 [TBL] [Abstract][Full Text] [Related]
17. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter. Wu J; Ao MT; Shao R; Wang HR; Yu D; Fang MJ; Gao X; Wu Z; Zhou Q; Xue YH Sci Rep; 2017 Sep; 7(1):10657. PubMed ID: 28878233 [TBL] [Abstract][Full Text] [Related]
18. BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency. Lu P; Shen Y; Yang H; Wang Y; Jiang Z; Yang X; Zhong Y; Pan H; Xu J; Lu H; Zhu H Sci Rep; 2017 Nov; 7(1):16646. PubMed ID: 29192216 [TBL] [Abstract][Full Text] [Related]